Literature DB >> 14512199

Synthesis, characterization, DNA-binding and cleavage studies of [Ru(bpy)2(actatp)]2+ and [Ru(phen)2(actatp)]2+ (actatp=acenaphthereno[1,2-b]-1,4,8,9-tetraazariphenylence).

Hong Deng1, Hong Xu, Yi Yang, Hong Li, Hui Zou, Liang Hu Qu, Liang-Nian Ji.   

Abstract

New ligand acenaphthereno[1,2-b]-1,4,8,9-tetraazariphenylence (actatp) and its complexes [Ru(bpy)(2)(actatp)](ClO(4))(2).2H(2)O (1) (bpy=2,2'-bipyridine) and [Ru(phen)(2)(actatp)](ClO(4))(2).2H(2)O (2) (phen=1,10-phenanthroline) have been synthesized and characterized by UV-vis, 1H NMR, and mass spectra. The electrochemical behavior of the two complexes was studied by cyclic voltammetry. The interaction of the two complexes with calf thymus DNA has been investigated by spectrophotometric methods and viscosity measurements. The experimental results suggest that both complexes bind to DNA through an intercalative mode. The circular dichroism signals of the dialysates of the racemic complexes against calf thymus DNA are discussed. When irradiated at 302 nm, both complexes have also been found to promote the photocleavage of plasmid pBR 322 DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512199     DOI: 10.1016/s0162-0134(03)00279-4

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  3 in total

1.  Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.

Authors:  Berelli Anupama; Airva Aruna; Vijjulatha Manga; Sreekanth Sivan; Madamsetty Vijay Sagar; Ravula Chandrashekar
Journal:  J Fluoresc       Date:  2017-01-17       Impact factor: 2.217

2.  Study on nucleic acid (CT-DNA and yeast tRNA) binding behaviors and cytotoxic properties of a heterodinuclear Ru(II)-Co(III) polypyridyl complex.

Authors:  Xiling Liang; Xiaoqing Zou; Lifeng Tan; Weiguo Zhu
Journal:  J Inorg Biochem       Date:  2010-08-18       Impact factor: 4.155

3.  Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds.

Authors:  Shyam Sunder A; Satyavati Dhulipala; Sreekanth Thota; Rajeshwar Yerra; Jan Balzarini; Erik De Clercq
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.